ADC Therapeutics (ADCT) Amortizatization of Intangibles (2020 - 2023)
ADC Therapeutics (ADCT) posted Amortizatization of Intangibles of $52000.0 for Q3 2023, up 1.96% sequentially from $51000.0 in Q2 2023, and up 67.74% YoY from $31000.0 in Q3 2022.
ADC Therapeutics (ADCT) Amortizatization of Intangibles (2020 - 2023) Analysis & Trends
ADC Therapeutics has reported Amortizatization of Intangibles for 4 years, with the latest figure at $52000.0 in Q3 2023.
- Quarterly Amortizatization of Intangibles rose 67.74% year-over-year to $52000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $185000.0 (up 52.89% YoY) and the FY2022 annual result came in at $118000.0, down 8.53% from the prior year.
- Amortizatization of Intangibles improved to $52000.0 in Q3 2023 per ADCT's latest filing, from $51000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $52000.0 in Q1 2023 and troughed at $8000.0 in Q2 2020.
- A 4-year average of $29933.3 and a median of $31000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2021 and 2022: Amortizatization of Intangibles jumped 375.0% in 2021, then decreased 18.42% in 2022.
- Over 4 years, Amortizatization of Intangibles stood at $19000.0 in 2020, then surged by 73.68% to $33000.0 in 2021, then dropped by 9.09% to $30000.0 in 2022, then soared by 73.33% to $52000.0 in 2023.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $52000.0, $51000.0, and $52000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 52,000.00 |
| Sep 30, 2023 | 52,000.00 |
| Jun 30, 2023 | 51,000.00 |
| Jun 30, 2023 | 51,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Dec 31, 2022 | 30,000.00 |
| Dec 31, 2022 | 30,000.00 |
| Sep 30, 2022 | 31,000.00 |
| Sep 30, 2022 | 31,000.00 |
| Jun 30, 2022 | 31,000.00 |
| Jun 30, 2022 | 31,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 33,000.00 |
| Dec 31, 2021 | 33,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Jun 30, 2021 | 38,000.00 |
| Jun 30, 2021 | 38,000.00 |